The outlook is as good as we could have expected. A lot better than could have been. The daily is not concerning, long run we are in good hands and these people want and need to be successful. We are no longer a story stock R&D company.. We are a manufacturer with validated results by the numbers. Numbers are trending in the right direction and should continue that way , fingers crossed for many quarters to come. I think we hold off the suiters and build value in CDMO as well as Oncologie. Two years down the road we will be better suited to maximize rev's in a buy out situation.
Hope we see some momentum short term it's just fun. It is the long term that matters and IMO we are good going forward.
News 
Market Data 
Discover 
